What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Colorectal cancer, Surgery, Cancer, Internal medicine and Rectum are his primary areas of study.
His Colorectal cancer research incorporates elements of Survival rate, Lymph node, Pathology, Metastasis and Adenocarcinoma.
Kenichi Sugihara works mostly in the field of Surgery, limiting it down to topics relating to General surgery and, in certain cases, Odds ratio.
The study incorporates disciplines such as Family medicine, Guideline, Methylation and DNA methylation in addition to Cancer.
His Internal medicine research integrates issues from Gastroenterology, Endocrinology and Oncology.
His Rectum study combines topics from a wide range of disciplines, such as Endoscopic mucosal resection, Anatomy, Sexual function, Prospective cohort study and Abdominal surgery.
His most cited work include:
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer (1142 citations)
- A Multicenter Study on Oncologic Outcome of Laparoscopic Gastrectomy for Early Cancer in Japan (556 citations)
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer (393 citations)
What are the main themes of his work throughout his whole career to date?
Kenichi Sugihara mainly investigates Colorectal cancer, Internal medicine, Oncology, Surgery and Cancer.
His study in Colorectal cancer is interdisciplinary in nature, drawing from both Cancer research, Lymph node, Pathology, Metastasis and Surgical oncology.
His work in Internal medicine covers topics such as Gastroenterology which are related to areas like Fluorouracil.
Kenichi Sugihara has researched Oncology in several fields, including Stage, Adjuvant chemotherapy, Proportional hazards model and Hazard ratio.
The concepts of his Surgery study are interwoven with issues in Gastrectomy and General surgery.
The Cancer study combines topics in areas such as Biomarker, Rectum and Methylation.
He most often published in these fields:
- Colorectal cancer (52.59%)
- Internal medicine (48.74%)
- Oncology (32.89%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (48.74%)
- Colorectal cancer (52.59%)
- Oncology (32.89%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Colorectal cancer, Oncology, Retrospective cohort study and Cancer.
His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with problems in Adenocarcinoma, Primary tumor and Hepatectomy.
Kenichi Sugihara combines subjects such as Stage, Proportional hazards model, Surgery, Lymph node and Metastasis with his study of Colorectal cancer.
His study explores the link between Oncology and topics such as Oxaliplatin that cross with problems in Fluorouracil.
His work carried out in the field of Retrospective cohort study brings together such families of science as Survival rate, Colectomy, Propensity score matching, Hepatology and Survival analysis.
His research integrates issues of Rectum, Cohort, Pathology and General surgery in his study of Cancer.
Between 2015 and 2021, his most popular works were:
- Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. (274 citations)
- Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial (94 citations)
- Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer. (94 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His primary scientific interests are in Colorectal cancer, Internal medicine, Oncology, Cancer and Retrospective cohort study.
His research in Colorectal cancer intersects with topics in Stage, Surgery, Lymph node, Confidence interval and Metastasis.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Hepatectomy.
Kenichi Sugihara interconnects Adjuvant chemotherapy, Regorafenib, Primary tumor and Population study in the investigation of issues within Oncology.
The various areas that Kenichi Sugihara examines in his Cancer study include Rectum, Cancer research, Kinase and Pathology.
The study incorporates disciplines such as Survival rate, Colectomy, Survival analysis and Nomogram in addition to Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
